KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
You can purchase shares of KalVista Pharma (NASDAQ:KALV) through any online brokerage.
Other companies in KalVista Pharma’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Korro Bio (NASDAQ:KRRO), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).
KalVista Pharma has a consensus price target of $26.17.
The stock price for KalVista Pharma (NASDAQ: KALV) is $8.5 last updated December 20, 2024 at 7:57 PM EST.
There are no upcoming dividends for KalVista Pharma.
KalVista Pharma’s Q3 earnings are confirmed for Monday, March 10, 2025.
There is no upcoming split for KalVista Pharma.
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.